GSK plc reports

Company location
London
GSK plc has filed 6,846 SEC EDGAR filings since 12 Jan 2001

SEC filing history

Showing 176-200 of 1,000 matching filings.

Per page
25
Current page
8
6-K File 001-15170

FILING OF GSK PLC 2025 ANNUAL REPORT ON FORM 20-F

Filing date
06 Mar 2026
Reporting date
06 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
IRANNOTICE File 001-15170

IRANNOTICE

Filing date
06 Mar 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

TRANSACTION IN OWN SHARES

Filing date
06 Mar 2026
Reporting date
06 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

GSK PUBLISHES ANNUAL REPORT 2025

Filing date
05 Mar 2026
Reporting date
05 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

TRANSACTION IN OWN SHARES

Filing date
05 Mar 2026
Reporting date
05 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

DIRECTOR/PDMR SHAREHOLDING

Filing date
04 Mar 2026
Reporting date
04 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

TRANSACTION IN OWN SHARES

Filing date
04 Mar 2026
Reporting date
04 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

GSK COMPLETES ACQUISITION OF RAPT THERAPEUTICS

Filing date
03 Mar 2026
Reporting date
03 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

TRANSACTION IN OWN SHARES

Filing date
03 Mar 2026
Reporting date
03 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
SC TO-T/A

SC TO-T/A

Filing date
03 Mar 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

TRANSACTION IN OWN SHARES

Filing date
02 Mar 2026
Reporting date
02 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

TOTAL VOTING RIGHTS

Filing date
02 Mar 2026
Reporting date
02 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

DIRECTOR/PDMR SHAREHOLDING

Filing date
27 Feb 2026
Reporting date
27 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

TRANSACTION IN OWN SHARES

Filing date
27 Feb 2026
Reporting date
27 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

LINERIXIBAT ACCEPTED FOR PRIORITY REVIEW IN CHINA

Filing date
26 Feb 2026
Reporting date
26 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

BEPIROVIRSEN ACCEPTED FOR JAPAN REGULATORY REVIEW

Filing date
26 Feb 2026
Reporting date
26 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

TRANSACTION IN OWN SHARES

Filing date
26 Feb 2026
Reporting date
26 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

DIRECTOR/PDMR SHAREHOLDING

Filing date
25 Feb 2026
Reporting date
25 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

DIRECTOR/PDMR SHAREHOLDING

Filing date
25 Feb 2026
Reporting date
25 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

GSK ENTERS AGREEMENT TO ACQUIRE 35PHARMA

Filing date
25 Feb 2026
Reporting date
25 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

TRANSACTION IN OWN SHARES

Filing date
25 Feb 2026
Reporting date
25 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

DIRECTOR/PDMR SHAREHOLDING

Filing date
24 Feb 2026
Reporting date
24 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

TRANSACTION IN OWN SHARES

Filing date
24 Feb 2026
Reporting date
24 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
SC TO-T/A

SC TO-T/A

Filing date
24 Feb 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .